Shopping Cart

Your shopping cart is currently empty

Acoramidis hydrochloride

Name: Acoramidis hydrochloride
Brand: TargetMol
SKU: T39740
Price: 48 USD
Availability: InStock
Rating: 5 (10 reviews)

Copy Product Info

😃Good

Catalog No. T39740Cas No. 2242751-53-5

Alias Alxn2060 hydrochloride, AG10 hydrochloride

Acoramidis hydrochloride (Alxn2060 hydrochloride) is an orally active and selective kinetic stabilizer of WT and V122I- TTR (transthyretin) . Acoramidis hydrochloride is used in the study for transthyretin amyloidosis.

Acoramidis hydrochloride

Copy Product Info

😃Good

Purity: 98.90%

Catalog No. T39740Alias Alxn2060 hydrochloride, AG10 hydrochlorideCas No. 2242751-53-5

Pack Size	Price	USA Warehouse	Global Warehouse
1 mg	$48	In Stock	In Stock
5 mg	$123	In Stock	In Stock
10 mg	$198	In Stock	In Stock
25 mg	$328	In Stock	In Stock
50 mg	$479	In Stock	In Stock
100 mg	$762	In Stock	In Stock
200 mg	$987	-	In Stock
1 mL x 10 mM (in DMSO)	$135	In Stock	In Stock

Add to Cart

Add to Quotation

In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]

All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Questions

Batch Information

Select Batch

Purity:98.90%

Appearance:Solid

Color:White

Resource Download

COA HNMR LCMS

Product Introduction

Bioactivity

Description	Acoramidis hydrochloride (Alxn2060 hydrochloride) is an orally active and selective kinetic stabilizer of WT and V122I- TTR (transthyretin) . Acoramidis hydrochloride is used in the study for transthyretin amyloidosis.
In vitro	Acoramidis (AG10, 0.1-10 μM for TTR ～5 μM) stabilizes V122I- and WT-TTR effectively, outperforming their efficacy in whole serum [1]. Acoramidis (AG10) stimulates mitochondrial QO2 concentration-dependently between 10 and 100 μM [3]. It exhibits minimal inhibition of the potassium ion channel hERG (IC50 > 100 μM) and several cytochrome P450 isozymes (IC50 > 50 μM) [low toxicity] [1]. Western Blot Analysis [1], using human serum (TTR ～5 μM), at concentrations of 0.1 and 10 μM, with a 72-hour incubation, shows AG10 is significantly more effective than tafamidis in stabilizing TTR, with 10 μM stabilizing almost all TTR in serum.
In vivo	Animal Model: Wistar rats [1] . Dosage: 50 mg/kg/d (Toxicity Analysis). Administration: Oral gavage, daily for 28 d. Result: Showed the plasma C max of ～40 μM and histopathological evaluation of liver, kidney, heart, spleen, thymus, and lung showed no signs of pathologic processes in the Acoramidis-treated animals
Synonyms	Alxn2060 hydrochloride, AG10 hydrochloride

Chemical Properties

Molecular Weight	328.77
Formula	C₁₅H₁₈ClFN₂O₃
Cas No.	2242751-53-5
Smiles	Cl.Cc1n[nH]c(C)c1CCCOc1cc(ccc1F)C(O)=O
Relative Density.	no data available

Storage & Solubility Information

Storage

Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Solubility Information

DMSO: 60 mg/mL (182.5 mM), Sonication is recommended.

In Vivo Formulation

10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (6.08 mM), Sonication is recommended.

Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.

Solution Preparation Table

DMSO

	1mg	5mg	10mg	50mg
1 mM	3.0416 mL	15.2082 mL	30.4164 mL	152.0820 mL
5 mM	0.6083 mL	3.0416 mL	6.0833 mL	30.4164 mL
10 mM	0.3042 mL	1.5208 mL	3.0416 mL	15.2082 mL
20 mM	0.1521 mL	0.7604 mL	1.5208 mL	7.6041 mL
50 mM	0.0608 mL	0.3042 mL	0.6083 mL	3.0416 mL
100 mM	0.0304 mL	0.1521 mL	0.3042 mL	1.5208 mL

Calculator

Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:

For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments

and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent

10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH₂O , the resulting working solution concentration would be 2 mg/mL.

Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSO TargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSO TargetMol | reagent stock solution to 400 μL PEG300 and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH₂O TargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.

All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc